Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Receivables (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Change in Receivables for 3 consecutive years, with $336045.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 391.5% to $336045.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $298972.0 through Dec 2025, up 368.34% year-over-year, with the annual reading at $298972.0 for FY2025, 368.34% up from the prior year.
  • Change in Receivables for Q4 2025 was $336045.0 at BioScience Health Innovations, up from -$326801.0 in the prior quarter.
  • The five-year high for Change in Receivables was $336045.0 in Q4 2025, with the low at -$326801.0 in Q3 2025.
  • Average Change in Receivables over 3 years is $32624.7, with a median of $5240.5 recorded in 2024.
  • Peak annual rise in Change in Receivables hit 4684.83% in 2025, while the deepest fall reached 7730.19% in 2025.
  • Over 3 years, Change in Receivables stood at $17732.0 in 2023, then surged by 285.59% to $68372.0 in 2024, then soared by 391.5% to $336045.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $336045.0, -$326801.0, and $296564.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.